查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1703261

C反應蛋白檢測市場－全球產業規模、佔有率、趨勢、機會及預測，依檢測類型、檢測範圍、疾病領域、最終用途產業、地區及競爭狀況分類，2020-2030年預測

C-reactive Protein Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Assay Type, By Detection Range, By Disease Area, By End-Use Industry, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球 C 反應蛋白 (CRP) 檢測市場價值為 16.802 億美元，預計將穩定成長，到 2030 年預計年複合成長率(CAGR) 為 2.10%。 CRP 檢測是一種廣泛使用的實驗室診斷工具，用於測量血液中 C 反應蛋白（一種指示發炎的肝臟產生的生物標記）的濃度。此測試有助於評估身體對感染、損​​傷和慢性病的發炎反應。

市場概覽
預測期 2026-2030
2024年市場規模 16.802億美元
2030年市場規模 19.0791億美元
2025-2030 年複合年成長率 2.10%
成長最快的領域 免疫比濁法
最大的市場 北美洲

醫療保健專業人員經常使用 CRP 測試來診斷和監測多種疾病，包括傳染病、自體免疫疾病、心血管疾病和術後併發症。以毫克/公升 (mg/L) 為單位報告的測試結果為發炎的嚴重程度和進展提供了寶貴的見解，支持及時診斷和疾病管理策略。

關鍵市場促進因素

發炎和傳染病的盛行率不斷上升

主要市場挑戰

CRP水平升高缺乏特異性

主要市場趨勢

個人化醫療日益受到重視

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：C反應蛋白檢測市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依檢測類型（免疫比濁法、ELISA、化學發光免疫分析法、其他）
    • 依檢測範圍（hs-CRP、常規CRP、cCRP）
    • 依疾病領域（心血管疾病、癌症、類風濕性關節炎、發炎性腸道疾病、子宮內膜異位症、紅斑性狼瘡、其他）
    • 依最終用途行業（醫院和診所、實驗室、輔助生活醫療設施、家庭護理、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美C反應蛋白檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲C反應蛋白檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太C反應蛋白檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲C反應蛋白檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲C反應蛋白檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第13章：全球C反應蛋白檢測市場：SWOT分析

第 14 章：競爭格局

  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corp
  • Quest Diagnostics
  • Siemens Healthineers AG
  • Abbott Laboratories Inc.
  • Merck KGaAA
  • Zoetis Inc.
  • Ortho Clinical Diagnostics
  • Getein Biotech, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 17192

Global C-reactive protein (CRP) testing market was valued at USD 1,680.20 million in 2024 and is expected to witness steady growth, with a projected compound annual growth rate (CAGR) of 2.10% through 2030. CRP testing is a widely utilized laboratory diagnostic tool that measures the concentration of C-reactive protein-a liver-produced biomarker indicative of inflammation-in the blood. This test is instrumental in evaluating the body's inflammatory response to infections, injuries, and chronic conditions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1680.20 Million
Market Size 2030USD 1907.91 Million
CAGR 2025-20302.10%
Fastest Growing SegmentImmunoturbidimetric Assays
Largest MarketNorth America

Healthcare professionals frequently use CRP testing to diagnose and monitor a broad range of conditions, including infectious diseases, autoimmune disorders, cardiovascular ailments, and post-surgical complications. Test results, reported in milligrams per liter (mg/L), provide valuable insight into the severity and progression of inflammation, supporting timely diagnosis and disease management strategies.

Key Market Drivers

Increasing Prevalence of Inflammatory and Infectious Diseases

A primary factor fueling market expansion is the growing global burden of inflammatory and infectious diseases. CRP testing is a critical diagnostic and prognostic tool used to detect and monitor a wide spectrum of conditions, including infections, autoimmune diseases, and cardiovascular disorders. As the incidence of these conditions rises globally, the demand for reliable inflammatory biomarkers like CRP continues to grow.

CRP testing is particularly important in managing chronic inflammatory diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and lupus, as well as acute conditions like sepsis and pneumonia. It is estimated that 18 million individuals are affected by RA worldwide, with women comprising 70% of cases and over half of the affected population aged 55 or older. Notably, 13 million people suffer from moderate to severe RA, where early diagnosis and rehabilitation can significantly improve quality of life.

The rising prevalence of autoimmune and inflammatory conditions-driven by a combination of genetic, environmental, and lifestyle factors-has prompted broader adoption of CRP testing in routine clinical diagnostics.

Key Market Challenges

Lack of Specificity in Elevated CRP Levels

One of the key challenges limiting the market's full potential is the non-specific nature of elevated CRP levels. While CRP is a reliable marker of inflammation, it does not provide diagnostic specificity regarding the underlying cause. This ambiguity can complicate clinical decision-making, requiring additional tests to identify the root condition, thereby prolonging diagnosis and treatment initiation.

Furthermore, due to its generalized nature, CRP testing is sometimes ordered inappropriately or excessively, particularly in cases where inflammation may not be clinically significant. This can lead to unnecessary healthcare spending and inefficient utilization of resources, contributing to diagnostic overuse and potential overdiagnosis.

Key Market Trends

Growing Emphasis on Personalized Medicine

The increasing focus on personalized medicine represents a transformative trend shaping the CRP testing market. Personalized medicine seeks to tailor medical treatment based on individual patient profiles, including genetic characteristics, lifestyle, and biomarker data. CRP serves as a critical biomarker for inflammation, enabling healthcare providers to design more targeted and effective treatment plans.

CRP testing plays a pivotal role in risk assessment, particularly for cardiovascular diseases, where elevated CRP levels may signal higher risk and prompt preventive interventions tailored to an individual's needs. It also supports continuous disease monitoring, allowing clinicians to track inflammation over time and make informed adjustments to treatment regimens based on changing CRP values.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corp
  • Quest Diagnostics
  • Siemens Healthineers AG
  • Abbott Laboratories Inc.
  • Merck KGaAA
  • Zoetis Inc.
  • Ortho Clinical Diagnostics
  • Getein Biotech, Inc.

Report Scope:

In this report, the Global C-reactive Protein Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

C-reactive Protein Testing Market, By Assay Type:

  • Immunoturbidimetric Assay
  • ELISA
  • Chemiluminescence Immunoassay
  • Others

C-reactive Protein Testing Market, By Detection Range:

  • hs-CRP
  • Conventional CRP
  • cCRP

C-reactive Protein Testing Market, By Disease Area:

  • Cardiovascular Diseases
  • Cancer
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Endometriosis
  • Lupus
  • Others

C-reactive Protein Testing Market, By End-User:

  • Hospitals & Clinics
  • Laboratories
  • Assisted Living Healthcare Facilities
  • Homecare
  • Others

C-reactive Protein Testing Market, By region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Australia
    • Japan
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global C-reactive Protein Testing Market.

Available Customizations:

Global C-reactive Protein Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. C-reactive Protein Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Assay Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others)
    • 5.2.2. By Detection Range (hs-CRP, Conventional CRP, cCRP)
    • 5.2.3. By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others)
    • 5.2.4. By End-Use Industry (Hospitals & Clinics, Laboratories, Assisted Living Healthcare Facilities, Homecare, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America C-reactive Protein Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Assay Type
    • 6.2.2. By Detection Range
    • 6.2.3. By Disease Are
    • 6.2.4. By End-Use Industry
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States C-reactive Protein Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Assay Type
        • 6.3.1.2.2. By Detection Range
        • 6.3.1.2.3. By Disease Are
        • 6.3.1.2.4. By End-Use Industry
    • 6.3.2. Canada C-reactive Protein Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Assay Type
        • 6.3.2.2.2. By Detection Range
        • 6.3.2.2.3. By Disease Are
        • 6.3.2.2.4. By End-Use Industry
    • 6.3.3. Mexico C-reactive Protein Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Assay Type
        • 6.3.3.2.2. By Detection Range
        • 6.3.3.2.3. By Disease Are
        • 6.3.3.2.4. By End-Use Industry

7. Europe C-reactive Protein Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Assay Type
    • 7.2.2. By Detection Range
    • 7.2.3. By Disease Are
    • 7.2.4. By End-Use Industry
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany C-reactive Protein Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Assay Type
        • 7.3.1.2.2. By Detection Range
        • 7.3.1.2.3. By Disease Are
        • 7.3.1.2.4. By End-Use Industry
    • 7.3.2. United Kingdom C-reactive Protein Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Assay Type
        • 7.3.2.2.2. By Detection Range
        • 7.3.2.2.3. By Disease Are
        • 7.3.2.2.4. By End-Use Industry
    • 7.3.3. Italy C-reactive Protein Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Assay Type
        • 7.3.3.2.2. By Detection Range
        • 7.3.3.2.3. By Disease Are
        • 7.3.3.2.4. By End-Use Industry
    • 7.3.4. France C-reactive Protein Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Assay Type
        • 7.3.4.2.2. By Detection Range
        • 7.3.4.2.3. By Disease Are
        • 7.3.4.2.4. By End-Use Industry
    • 7.3.5. Spain C-reactive Protein Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Assay Type
        • 7.3.5.2.2. By Detection Range
        • 7.3.5.2.3. By Disease Are
        • 7.3.5.2.4. By End-Use Industry

8. Asia-Pacific C-reactive Protein Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Assay Type
    • 8.2.2. By Detection Range
    • 8.2.3. By Disease Are
    • 8.2.4. By End-Use Industry
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China C-reactive Protein Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Assay Type
        • 8.3.1.2.2. By Detection Range
        • 8.3.1.2.3. By Disease Are
        • 8.3.1.2.4. By End-Use Industry
    • 8.3.2. India C-reactive Protein Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Assay Type
        • 8.3.2.2.2. By Detection Range
        • 8.3.2.2.3. By Disease Are
        • 8.3.2.2.4. By End-Use Industry
    • 8.3.3. Japan C-reactive Protein Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Assay Type
        • 8.3.3.2.2. By Detection Range
        • 8.3.3.2.3. By Disease Are
        • 8.3.3.2.4. By End-Use Industry
    • 8.3.4. South Korea C-reactive Protein Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Assay Type
        • 8.3.4.2.2. By Detection Range
        • 8.3.4.2.3. By Disease Are
        • 8.3.4.2.4. By End-Use Industry
    • 8.3.5. Australia C-reactive Protein Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Assay Type
        • 8.3.5.2.2. By Detection Range
        • 8.3.5.2.3. By Disease Are
        • 8.3.5.2.4. By End-Use Industry

9. South America C-reactive Protein Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Assay Type
    • 9.2.2. By Detection Range
    • 9.2.3. By Disease Are
    • 9.2.4. By End-Use Industry
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil C-reactive Protein Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Assay Type
        • 9.3.1.2.2. By Detection Range
        • 9.3.1.2.3. By Disease Are
        • 9.3.1.2.4. By End-Use Industry
    • 9.3.2. Argentina C-reactive Protein Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Assay Type
        • 9.3.2.2.2. By Detection Range
        • 9.3.2.2.3. By Disease Are
        • 9.3.2.2.4. By End-Use Industry
    • 9.3.3. Colombia C-reactive Protein Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Assay Type
        • 9.3.3.2.2. By Detection Range
        • 9.3.3.2.3. By Disease Are
        • 9.3.3.2.4. By End-Use Industry

10. Middle East and Africa C-reactive Protein Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Assay Type
    • 10.2.2. By Detection Range
    • 10.2.3. By Disease Are
    • 10.2.4. By End-Use Industry
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa C-reactive Protein Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Assay Type
        • 10.3.1.2.2. By Detection Range
        • 10.3.1.2.3. By Disease Are
        • 10.3.1.2.4. By End-Use Industry
    • 10.3.2. Saudi Arabia C-reactive Protein Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Assay Type
        • 10.3.2.2.2. By Detection Range
        • 10.3.2.2.3. By Disease Are
        • 10.3.2.2.4. By End-Use Industry
    • 10.3.3. UAE C-reactive Protein Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Assay Type
        • 10.3.3.2.2. By Detection Range
        • 10.3.3.2.3. By Disease Are
        • 10.3.3.2.4. By End-Use Industry

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global C-reactive Protein Testing Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Thermo Fisher Scientific, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. F. Hoffmann-La Roche Ltd.
  • 14.3. Danaher Corp
  • 14.4. Quest Diagnostics
  • 14.5. Siemens Healthineers AG
  • 14.6. Abbott Laboratories Inc.
  • 14.7. Merck KGaAA
  • 14.8. Zoetis Inc.
  • 14.9. Ortho Clinical Diagnostics
  • 14.10.Getein Biotech, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer